Despite the huge efforts globally underway for preventing or limiting the spread of severe
acute respiratory coronavirus disease 2 (SARS-CoV-2), the coronavirus disease 2019 …

Welcome to another issue of Seminars in Thrombosis and Hemostasis (STH). This issue is
published under the “continuing banner” of “Maintaining hemostasis and preventing …

To slow down the coronavirus disease 2019 (COVID‐19) pandemic an unequalled
vaccination campaign was initiated. Despite proven efficacy and safety, a rare but potentially …

Background Genetic-based COVID-19 vaccines have proved to be highly effective in
reducing the risk of hospitalization and death. Because they were first distributed in a large …

Background Vaccination is the leading approach in combatting the severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) pandemic. ChAdOx1 nCoV‐19 vaccination …

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a
constantly evolving virus, resulting in an increased burden on the existing COVID-19 …

Coronavirus disease 2019 (COVID-19) vaccines are associated with serious
thromboembolic or thrombocytopenic events including vaccine-induced immune …

Millions of people have been infected and died because of the COVID-19 pandemic since
December 2019, which is not the first pandemic the world has faced (1). Older people and …

Recent studies have indicated that sequentially administering SARS-CoV-2 vaccines can
result in increased antibody and cellular immune responses. In this study, we compared …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), is spreading throughout the world at an alarming …